What is the brand name for Tirzepatide?
The most common brand name for Tirzepatide is Mounjaro / Zepbound.
PTCB TOP 200 · #110
Tirzepatide
Mounjaro / Zepbound
Tirzepatide is the generic name for the brand-name drug Mounjaro. It is a dual gip/glp-1 receptor agonist used to treat type 2 diabetes, weight loss. On the PTCE Top 200 drug list, Tirzepatide ranks #110 and is one of the most frequently tested endocrine/diabetes medications — commonly quizzed on its brand–generic pair, drug class, and key side effects.
| Generic name | Tirzepatide |
|---|---|
| Brand name(s) | Mounjaro / Zepbound |
| Drug class | Dual GIP/GLP-1 receptor agonist |
| Class group | Endocrine/Diabetes |
| Common use | type 2 diabetes, weight loss |
| DEA schedule | Unscheduled |
| Availability | Prescription only (Rx) |
What is Tirzepatide used for?
Incretin‑based injectable used for type 2 diabetes to improve glycemic control; some tirzepatide products are also approved for chronic weight management in appropriate patients.
What drug class is Tirzepatide?
Tirzepatide is a Dual GIP/GLP-1 receptor agonist in the Endocrine/Diabetes group. Knowing the class is the fastest way to predict its uses, side effects, and the brand↔generic pairs the PTCE tests.
Common side effects of Tirzepatide
- arrow_rightNausea
- arrow_rightDiarrhea
- arrow_rightVomiting
- arrow_rightDecreased appetite
- arrow_rightConstipation
- arrow_rightAbdominal pain
Major interactions
- arrow_rightInsulin or sulfonylureas ↑ hypoglycemia risk—may need dose reduction
- arrow_rightDelays gastric emptying → can affect absorption of some oral meds (use caution with narrow‑therapeutic‑index drugs)
- arrow_rightAvoid in patients with history of MTC/MEN2; monitor for pancreatitis symptoms as clinically directed
Is Tirzepatide a controlled substance?
No. Tirzepatide is not a federally controlled substance (it is unscheduled by the DEA).
warning Boxed warning
WARNING: RISK OF THYROID C‑CELL TUMORS — caused thyroid C‑cell tumors in rats; contraindicated in patients with medullary thyroid carcinoma (MTC) or MEN2.
How to remember Tirzepatide (PTCE mnemonic)
MOUNJ-aro brings a MOUNTain of weight loss — tirzePATIDE = dual GIP/GLP-1 (stronger than Ozempic). Weekly inject, N/V; thyroid C-cell warning (boxed); pancreatitis.
lightbulb
PTCE exam tip
Tirzepatide is the DUAL GIP/GLP-1 agonist — one generic, two brands by use: Mounjaro (diabetes) vs Zepbound (weight) — with the same thyroid-tumor boxed warning as semaglutide.
Tirzepatide FAQ
What is Tirzepatide used for?
Tirzepatide is used to treat type 2 diabetes, weight loss. Incretin‑based injectable used for type 2 diabetes to improve glycemic control; some tirzepatide products are also approved for chronic weight management in appropriate patients.
What drug class is Tirzepatide?
Tirzepatide is a Dual GIP/GLP-1 receptor agonist (Endocrine/Diabetes group).
Is Tirzepatide a controlled substance?
No. Tirzepatide is not a federally controlled substance (it is unscheduled by the DEA).
Study guides that cover Tirzepatide
Free, in-depth guides to the patterns behind this drug — no app needed.
Drug suffix cheat sheetthe suffix that gives away this drug's class
How to memorize the Top 200 drugsa method for locking in brand↔generic pairs
How hard is the PTCE?what the pass rate really means
Failed the PTCB? The comeback planwhat to do if the first attempt failsSee all PTCE study guides or browse the full Top 200 drug list.
Drill Tirzepatide the way the PTCE asks it
RxReflex turns the Top 200 drugs into fast flashcard rounds, a guided Learn path, pharmacy math, and 40+ cheat sheets. Free to start.
Related drugs in the Endocrine/Diabetes group
Written and reviewed by the RxReflex Content Team. Educational use only — not medical advice. Verify clinical specifics with your pharmacist or a current label source such as DailyMed. RxReflex is not affiliated with or endorsed by the Pharmacy Technician Certification Board (PTCB).